Sai Bikkina

SB

Statistics

Publications

1

Citations

17

H-Index

1

Active since

2022

Sai Bikkina is an author at The University of Texas MD Anderson Cancer Center specializing in pd-l1 blockade, durvalumab therapy, and immune checkpoint inhibitors.

Publications per year

2022–2022

1

Publications

1